close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eiger BioPharmaceuticals, Inc. - Common Stock (NQ:EIGR)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eiger BioPharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Eiger BioPharma Shuns Plans For FDA Emergency Use Nod For COVID-19 Treatment
 
Via Benzinga
FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect
 
Via Benzinga
EMA's Advisory Committee Recommends Eiger's Zokinvy In Premature Aging Disorder
 
Via Benzinga
EIGER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ROSEN, A TOP RANKED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Eiger Biopharmaceutials, Inc. (EIGR)
From Robbins LLP
Via Business Wire
NASDAQ:EIGR Investor Notice Investigation Announced over Potential Wrongdoing at Eiger BioPharmaceuticals, Inc.
San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Certain directors of Eiger BioPharmaceuticals, Inc are under investigation over potential breaches of fiduciary duties. 
Via SBWire
EQUITY ALERT: Rosen Law Firm Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
From The Rosen Law Firm, P.A.
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million. 
Via Benzinga
NASDAQ:EIGR Investor Notice: Investigation over Possible Securities Laws Violations by Eiger BioPharmaceuticals, Inc.
San Diego, CA -- (SBWIRE) -- 09/21/2022 -- Eiger BioPharmaceuticals, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements. 
Via SBWire
Starbucks To $94? Here Are 5 Other Price Target Changes For Wednesday
Citigroup raised the price target on Starbucks Corporation (NASDAQ: SBUX) from $90 to $94. Citigroup analyst Jon Tower maintained a Neutral rating on the stock. Starbucks shares fell 0.1% to $84.50 in... 
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. 
Via Benzinga
Dow Tumbles Over 200 Points; ChannelAdvisor Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Nasdaq Drops 100 Points; DWAC Shares Plummet
U.S. stocks traded lower midway through trading, with the Nasdaq dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around... 
Via Benzinga
Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday
  
Via Benzinga
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist... 
Via Benzinga
US Stocks Trade Lower; Dow Drops Over 100 points
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%,... 
Via Benzinga
Eiger BioPharmaceuticals Earnings Perspective: Return On Capital Employed
According to Benzinga Pro data, during Q2, Eiger BioPharmaceuticals (NASDAQ:EIGR) posted sales of $4.09 million. Earnings were up 3.35%, but Eiger BioPharmaceuticals still reported an overall loss of... 
Via Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
  
Via Benzinga
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:... 
Via Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results. Allego N.V. (NASDAQ: ALLG) shares gained 45.5% to $9.40. Spartan... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today